Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	906	621	425	367	564	318
Market Cap Growth	43.13%	46.27%	15.75%	-34.95%	77.16%	76.78%
Enterprise Value	816.75	499.36	300.01	221.77	410.92	197.83
Last Close Price	4.71	3.27	2.50	2.33	3.89	3.55
PE Ratio	-	-8.61	-5.68	-5.07	-4.69	-3.55
PS Ratio	62.02	100.66	23.41	9.40	51.33	46.05
PB Ratio	11.68	6.38	4.01	2.68	3.33	3.12
P/TBV Ratio	11.63	6.23	3.91	2.57	2.44	2.64
P/FCF Ratio	-	-9.55	-4.88	-10.23	-8.25	-6.16
P/OCF Ratio	-	-9.58	-4.94	-10.38	-8.35	-6.19
EV/Sales Ratio	55.92	80.92	16.54	5.68	37.40	28.61
EV/EBITDA Ratio	-	-6.66	-3.91	-3.46	-5.73	-3.54
EV/EBIT Ratio	-	-6.54	-3.84	-3.39	-5.59	-3.42
EV/FCF Ratio	-	-7.68	-3.45	-6.18	-6.01	-3.83
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-0.02	-0.02	-0.02	-0.03	-0.04	-0.05
Debt / FCF Ratio	-0.02	-0.02	-0.02	-0.06	-0.04	-0.06
Net Debt / Equity Ratio	-1.20	-1.25	-1.17	-1.06	-0.90	-1.18
Net Debt / EBITDA Ratio	2.01	1.62	1.62	2.26	2.13	2.15
Net Debt / FCF Ratio	2.05	1.87	1.43	4.04	2.23	2.33
Asset Turnover	0.13	0.04	0.11	0.20	0.06	0.06
Quick Ratio	18.25	8.01	5.68	4.51	13.92	13.06
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.38
Return on Equity (ROE)	-48.38%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-40.80%	-55.28%	-45.97%	-30.50%	-43.05%	-47.65%
Return on Invested Capital (ROIC)	-10697.83%	-1582.23%	-384.71%	-172.25%	-342.03%	-953.34%
Return on Capital Employed (ROCE)	-44.87%	-64.13%	-54.91%	-36.79%	-45.84%	-51.33%
Earnings Yield	-4.67%	-11.62%	-17.60%	-19.74%	-21.34%	-28.17%
FCF Yield	-5.01%	-10.47%	-20.47%	-9.78%	-12.12%	-16.23%
Buyback Yield / Dilution	-0.65%	-8.37%	-7.22%	-8.67%	-24.33%	-27.25%

Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q